
Summit Therapeutics Inc. (SMMT)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
21.46 - Open
16.02 - Bid 16.07 x 1100
- Ask 16.16 x 5200
- Day's Range
15.14 - 16.81 - 52 Week Range
13.83 - 30.98 - Volume
18,118,769 - Avg. Volume
3,193,593 - Market Cap (intraday)
12.507B - Beta (5Y Monthly) -1.25
- PE Ratio (TTM)
-- - EPS (TTM)
-1.59 - Earnings Date (est.) Apr 30, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
30.90
Recent News: SMMT
View MorePerformance Overview: SMMT
Trailing total returns as of 5/1/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends: SMMT
View MoreAnalyst Insights: SMMT
View MoreStatistics: SMMT
View MoreValuation Measures
-
Market Cap
12.51B
-
Enterprise Value
11.93B
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
--
-
Price/Book (mrq)
22.91
-
Enterprise Value/Revenue
--
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
--
-
Return on Equity (ttm)
--
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-1.21B
-
Diluted EPS (ttm)
-1.59
Balance Sheet and Cash Flow
-
Total Cash (mrq)
713.45M
-
Total Debt/Equity (mrq)
3.17%
-
Levered Free Cash Flow (ttm)
--
Compare To: SMMT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.








